Company Directory > CRO > Red Nucleus
Red Nucleus is a global strategic partner for the life sciences industry, providing a comprehensive suite of services across the entire product lifecycle. Their offerings include advisory, scientific services, medical communications, market access, and learning and development solutions. The company acts as a "red thread" connecting these disparate functions to help pharmaceutical and biotech companies navigate complex commercialization challenges, improve health outcomes, and accelerate success. Headquartered in Yardley, Pennsylvania, Red Nucleus has expanded significantly through strategic acquisitions of specialized firms in consulting, medical communications, and clinical software. The company serves over 200 organizations, including many of the top 25 global pharmaceutical companies, and is supported by private equity investment to drive further growth and innovation in its service portfolio.
CLASSIFICATION
Company Type:CRO
Therapeutic Areas:
Industry:CRO
Sub-Industry:Medical Communications and Life Sciences Advisory
SIZE & FINANCIALS
Employees:501-1000
Revenue:$250M-$500M
Founded:2014
Ownership:subsidiary
Status:operating
FUNDING
Investors:THL Partners
0
CORPORATE STRUCTURE
Parent Company:THL Partners
Acquired By:THL Partners (Thomas H. Lee Partners) (2024-10-01)
Subsidiaries:Jupiter Life Science Consulting, Alpha Group, Actando, iTakeControl, INVIVO
Key Partnerships:Serves 200+ organizations including top 25 global pharma companies
COMPETITION
Position:Leader
Competitors:Precision Medicine Group, WuXi AppTec, ANI Pharmaceuticals
LINKS
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Red Nucleus and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Red Nucleus. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.